A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...
Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.
A federal judge certified several classes of direct and end-payer purchasers for test trials in drug price-fixing litigation against makers of two generic drugs, clomipramine and clobetasol.
Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...
Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents ...
The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results